Vaccination in pediatric transplantation-General recommendations. A position paper by the European Reference Network TransplantChild [0.03%]
儿童移植患者的疫苗接种-一般性推荐意见。欧洲参考网络TransplantChild立场文件
Valeria Casotti,Francesco Saglio,Adriana Balduzzi et al.
Valeria Casotti et al.
Infectious diseases remain a leading cause of morbidity and mortality among pediatric transplant recipients, despite significant advances in transplantation management. Vaccination is the most effective strategy to prevent infections; howev...
Disparities in child height at the time of inflammatory bowel disease diagnosis [0.03%]
儿童炎症性肠病诊断时身高的差异分析
Joann M Samalik,Grace J Lee,Zubin J Modi et al.
Joann M Samalik et al.
Objectives: Growth delay is associated with severe disease at inflammatory bowel disease (IBD) diagnosis. Variation in height at diagnosis is unknown. We hypothesize that growth delay at diagnosis is more common among ind...
Glucagon-like peptide-1 receptor agonists in pediatrics: The pancreatology perspective [0.03%]
胰高糖素样肽-1受体激动剂在儿科应用：胰腺病学观点
Rosara Bass,Chinenye R Dike,Jennifer M Ladd et al.
Rosara Bass et al.
Effectiveness of rifaximin in reducing central line-associated bloodstream infections in pediatric intestinal failure [0.03%]
利福昔明减少小儿肠外营养相关血流感染的有效性研究
Emma Johnson,Claire Konicek,Nathan Lamb et al.
Emma Johnson et al.
Objectives: Due to their dependence on parenteral nutrition, patients with intestinal failure (IF) are at an increased risk of central line-associated blood stream infections (CLABSIs). Ethanol lock therapies (ELTs) reduc...
Assessment of professional practise on Helicobacter pylori in paediatrics: A pan-European study [0.03%]
儿童幽门螺杆菌感染的诊断与治疗专业实践评估：一项欧洲范围的研究
Marta Tavares,Angelika Kindermann,Claudio Romano et al.
Marta Tavares et al.
Objectives: Recent guidelines provide insightful information on the diagnosis and treatment of Helicobacter pylori infection. The knowledge of the latest guidelines for European paediatric gastroenterologists is currently...
Infliximab originator and biosimilars have similar efficacy in children with inflammatory bowel disease [0.03%]
英夫利西单抗原研药和类似物在儿童炎症性肠病患者中的疗效相当
Ross M Maltz,Jeremy Adler;ImproveCareNow Pediatric IBD Learning Health System
Ross M Maltz
Objectives: To evaluate whether children with inflammatory bowel disease (IBD) who initiate infliximab originator versus biosimilar experience similar clinical outcomes at 12 months. ...
The ImproveCareNow Registry: Prediction of remission rates in paediatric Crohn's disease [0.03%]
改善护理现在登记处：儿科克罗恩病缓解率的预测
Jonathan Van Hecke,Gigi Veereman,Koen Huysentruyt et al.
Jonathan Van Hecke et al.
Objectives: Identifying predictors of poor outcomes (POPO) in paediatric Crohn's disease (CD) may guide therapy. We assessed predictors of 2-year non-remission (primary outcome) and time to first remission (TFR), corticos...
Are there age-related differences in the frequency of post-reflux peristaltic waves during impedance-pH monitoring? [0.03%]
不同年龄段患者食管高分辨率测压中反流后蠕动频率的差异性分析
Judith Cohen Sabban,Jhoanna Valery Adauto Luizaga,Florencia Grisel Ursino et al.
Judith Cohen Sabban et al.
Objectives: The post-reflux swallow-induced peristaltic wave (PSPW) reflects esophageal chemical clearance. Pediatric data on this parameter remain limited. The aim of this study was to evaluate the behavior of the PSPW i...
Harnessing language in pediatric disorders of gut-brain interaction: A practical guide to suggestive communication [0.03%]
儿科胃肠道疾病实用的语言指导：避免暗示性语言的方法
Arine M Vlieger,Julie Snyder,Sam Nurko et al.
Arine M Vlieger et al.